Dr. Marcucci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Division of Leukemia
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-389-3061- Is this information wrong?
Summary
- Dr. Guido Marcucci is Medical Oncologist is affiliated with City of Hope's Helford Clinical Research Hospital. He is Chief of the Division of Leukemia, Chair and Professor of the Dept. of Hematologic Malignancies Translational Science, Director of the Gehr Family Center for Leukemia Research, and Director of the Hematopoietic Tissue Biorepository. He is experienced in hematologic oncology, leukemia, hematopoietic stem cell transplantation, flow cytometry, cytogenetics, and drug delivery systems.
Education & Training
- Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1997 - 1998
- University at BuffaloFellowship, Hematology and Medical Oncology, 1995 - 1997
- SUNY at Buffalo Graduate Medical-Dental Education Consortium (Millard Fillmore)Residency, Internal Medicine, 1990 - 1993
- University of Cattolica del Sacro CuoreClass of 1987
Certifications & Licensure
- CA State Medical License 2015 - 2024
- OH State Medical License 1997 - 2016
- NY State Medical License 1995 - 1998
- PA State Medical License 1993 - 1996
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Start of enrollment: 1999 Oct 01
- FR901228 in Treating Patients With Hematologic Cancer Start of enrollment: 2002 Jan 01
- Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia Start of enrollment: 2002 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.Al Malki, M. M., Jianying Zhang, Jose Tinajero, Hoda Pourhassan, Vinod Pullarkat, Vaibhav Agrawal, Paul Koller, Ahmed Aribi, Amandeep Salhotra, Karamjeet Sandhu, Haris...> ;British Journal of Haematology. 2024 Mar 31
- Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, Sergio Branciamore, David Frankhouser, Denis O'Meally, Ya-Huei Kuo, Russell Rockne, Nataly Kravchenko-Balasha, Soheil M...> ;NPJ Systems Biology and Applications. 2024 Mar 25
- Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of.Mark J Levis, Mehdi Hamadani, Brent Logan, Richard J Jones, Anurag K Singh, Mark Litzow, John R Wingard, Esperanza B Papadopoulos, Alexander E Perl, Robert J Soiffer, ...> ;Journal of Clinical Oncology. 2024 Mar 12
- Join now to see all
Journal Articles
- Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic LeukaemiaMichael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature
Abstracts/Posters
- Spred1 Insufficiency in the Hematopoietic and/or Vascular Compartments of the Bone Marrow (BM) Niche Promotes Aggressive Leukemogenesis in Chronic Myelogenous Leukemia...Guido Marcucci, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- HDAC8 Promotes MLL-Rearranged Acute Myeloid Leukemia By Inhibiting p53 AcetylationGuido Marcucci, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Effective Novel Fto Inhibitors Show Potent Anti-Cancer Efficacy and Suppress Drug ResistanceClinically Relevant AbstractGuido Marcucci, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Genomic Determinants of Response to Blinatumomab in Relapsed/Refractory (R/R) B-Cell Precursor Acute Lymphoblastic Leukemia in AdultsClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Cytokine Gene Polymorphisms Are Associated with Disease Response to Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- CAR22/19 Cocktail Therapy for Patients with Refractory/Relapsed B-Cell MalignanciesClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 MutationJune 2017
Press Mentions
- Cellworks Biosimulation Study Reveals Biomarkers That Predict Response to Hypomethylating Agents and Patient Survival in MDSDecember 12th, 2022
- myCare-023 Finds Cellworks Personalized Biosimulation a Stronger Predictor of Therapy Response for AML Patients Than Physician Prescribed TreatmentDecember 14th, 2021
- myCare-023 Finds Cellworks Personalized Biosimulation a Stronger Predictor of Therapy Response for AML Patients Than Physician Prescribed TreatmentDecember 14th, 2021
- Join now to see all
Other Languages
- Italian
Hospital Affiliations
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: